Arthrosi Therapeutics

Acquisition, funding and merger involving Arthrosi Therapeutics.

• Arthrosi Therapeutics has just announced a $75 Million fundraising (posted on July 12 2023).

View the org chart displaying its 7 main executives

Most searched biographies at Arthrosi Therapeutics

• Litain Yeh, Chief Executive Officer
• Xin Xie, Director
• Hanxiong Li, Chairman of the Board

Create your alert
to follow the executive moves at Arthrosi Therapeutics.

Arthrosi Therapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Arthrosi Therapeutics

• News & Media - Arthrosi
• Arthrosi Therapeutics, Inc. Announces Impressive Phase 2a Study Results - Arthrosi

Social media about Arthrosi Therapeutics

• Arthrosi Therapeutics on Wikipedia, Google News & Yahoo Finance
• Arthrosi Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Litain Yeh

Call Arthrosi Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error